एपीए उद्धरण

Ujjani, C., Wang, H., Skarbnik, A., Trivedi, N., Ramzi, P., Khan, N., & Cheson, B. D. (2018). A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. Blood Adv.

शिकागो स्टाइल उद्धरण

Ujjani, Chaitra, Hongkun Wang, Alan Skarbnik, Neel Trivedi, Pari Ramzi, Nadia Khan, और Bruce D. Cheson. "A Phase 1 Study of Lenalidomide and Ibrutinib in Combination With Rituximab in Relapsed and Refractory CLL." Blood Adv 2018.

एमएलए उद्धरण

Ujjani, Chaitra, et al. "A Phase 1 Study of Lenalidomide and Ibrutinib in Combination With Rituximab in Relapsed and Refractory CLL." Blood Adv 2018.